These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26035734)

  • 1. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation.
    Roine J; Kaasalainen M; Peurla M; Correia A; Araújo F; Santos HA; Murtomaa M; Salonen J
    Mol Pharm; 2015 Jul; 12(7):2254-64. PubMed ID: 26035734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the interactions of enteric and hydrophilic polymers to enhance dissolution of griseofulvin following hot melt extrusion processing.
    Bennett RC; Keen JM; Bi YV; Porter S; Dürig T; McGinity JW
    J Pharm Pharmacol; 2015 Jul; 67(7):918-38. PubMed ID: 25645386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast-dissolving microparticles fail to show improved oral bioavailability.
    Wong SM; Kellaway IW; Murdan S
    J Pharm Pharmacol; 2006 Oct; 58(10):1319-26. PubMed ID: 17034654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
    Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
    Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles.
    Wong SM; Kellaway IW; Murdan S
    Int J Pharm; 2006 Jul; 317(1):61-8. PubMed ID: 16647232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
    Zecevic DE; Meier R; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
    Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
    J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable nanoparticles from prosopisylated cellulose as a platform for enhanced oral bioavailability of poorly water-soluble drugs.
    Kenechukwu FC; Dias ML; Ricci-Júnior E
    Carbohydr Polym; 2021 Mar; 256():117492. PubMed ID: 33483021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregated Solution Morphology of Poly(acrylic acid)-Poly(styrene) Block Copolymers Improves Drug Supersaturation Maintenance and Caco-2 Cell Membrane Permeation.
    Purchel AA; Boyle WS; Reineke TM
    Mol Pharm; 2019 Nov; 16(11):4423-4435. PubMed ID: 31633362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement.
    Krull SM; Ma Z; Li M; Davé RN; Bilgili E
    Drug Dev Ind Pharm; 2016; 42(7):1073-85. PubMed ID: 26567632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteric and hydrophilic polymers enhance dissolution and absorption of poorly soluble acidic drugs based on micro-environmental pH-modifying solid dispersion.
    Zhang S; Xu X; Sun W; Zhang Z; Pan B; Hu Q
    Eur J Pharm Sci; 2022 Jan; 168():106074. PubMed ID: 34798261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles.
    Bimbo LM; Mäkilä E; Laaksonen T; Lehto VP; Salonen J; Hirvonen J; Santos HA
    Biomaterials; 2011 Apr; 32(10):2625-33. PubMed ID: 21194747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib.
    Riikonen J; Correia A; Kovalainen M; Näkki S; Lehtonen M; Leppänen J; Rantanen J; Xu W; Araújo F; Hirvonen J; Järvinen K; Santos HA; Lehto VP
    Biomaterials; 2015 Jun; 52():44-55. PubMed ID: 25818412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
    Wang XQ; Zhang Q
    Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior.
    Vippagunta SR; Wang Z; Hornung S; Krill SL
    J Pharm Sci; 2007 Feb; 96(2):294-304. PubMed ID: 17051588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal.
    Singh G; Pai RS
    Drug Deliv; 2016; 23(2):532-9. PubMed ID: 24963752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
    Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced intestinal permeability and oral bioavailability of enalapril maleate upon complexation with the cationic polymethacrylate Eudragit E100.
    Ramírez-Rigo MV; Olivera ME; Rubio M; Manzo RH
    Eur J Pharm Sci; 2014 May; 55():1-11. PubMed ID: 24456933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.